Pfizer and BioNTech said a lower dose of their COVID-19 vaccine induced a robust immune response in 5 to 11-year-olds, and they plan to seek authorization to use the shot in children in that age range in the U.S., Europe and elsewhere as soon as possible https://t.co/ReiRxnaWtI pic.twitter.com/aJV3l8OvIw— Reuters (@Reuters) September 20, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


